Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

NCT ID: NCT06495918

Last Updated: 2025-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

825 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-27

Study Completion Date

2027-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age- Related Macular Degeneration

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neovascular Age-related Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OTX-TKI Re-dose

Group Type EXPERIMENTAL

OTX-TKI

Intervention Type DRUG

Intravitreal Injection of OTX-TKI

Aflibercept 2mg on label

Group Type ACTIVE_COMPARATOR

Aflibercept

Intervention Type DRUG

Intravitreal Injection of 2mg of aflibercept

Aflibercept 8mg high dose

Group Type OTHER

Aflibercept

Intervention Type DRUG

Intravitreal Injection of 8mg of aflibercept

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OTX-TKI

Intravitreal Injection of OTX-TKI

Intervention Type DRUG

Aflibercept

Intravitreal Injection of 2mg of aflibercept

Intervention Type DRUG

Aflibercept

Intravitreal Injection of 8mg of aflibercept

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Treatment naïve juxtafoveal and/or SFNV secondary to Neovascular Age- Related Macular Degeneration (nAMD) with leakage involving the fovea in the study eye prior to Screening, or have a diagnosis of Neovascular Age- Related Macular Degeneration (nAMD) in study eye within 3 months prior to screening and received up to 2 monthly injections of 2 mg aflibercept with last injection approximately 4 weeks prior to Screening
* Have provided written consent

Exclusion Criteria

* Monocular subject or Best Corrected Visual Acuity (BCVA) score of \<20 ETDRS letters or 20/400 in fellow eye at Screening
* Have evidence of a scar, fibrosis, or atrophy of \>50% of the total lesion in the study eye.
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fortrea

INDUSTRY

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role collaborator

Ocular Therapeutix, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dilsher Dhoot, MD

Role: PRINCIPAL_INVESTIGATOR

California Retina Consultants (CRC) - Santa Barbara

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Associated Retina Consultant

Gilbert, Arizona, United States

Site Status

Associated Retina Consultants, Ltd.

Phoenix, Arizona, United States

Site Status

Retinal Research Institute, LLC

Phoenix, Arizona, United States

Site Status

Retina Macula Institute of Arizona

Scottsdale, Arizona, United States

Site Status

California Retina Consultants

Bakersfield, California, United States

Site Status

The Retina Partners

Encino, California, United States

Site Status

Retina Consultants of Orange County

Fullerton, California, United States

Site Status

Atlantis Eyecare

Huntington Beach, California, United States

Site Status

Salehi Retina Institute, Inc., dba Retina Associates of Southern California

Huntington Beach, California, United States

Site Status

Kaiser Permanente Division of Research

Oakland, California, United States

Site Status

California Retina Consultants

Oxnard, California, United States

Site Status

Stanford Health Care - Byers Eye Institute

Palo Alto, California, United States

Site Status

Stanford University School of Medicine, Byers Eye Institute

Palo Alto, California, United States

Site Status

California Eye Specialists Medical Group, INC

Pasadena, California, United States

Site Status

Retinal Consultants Medical Group

Sacramento, California, United States

Site Status

Orange County Retina Medical Group

Santa Ana, California, United States

Site Status

California Retina Consultants

Santa Barbara, California, United States

Site Status

Macula Retina Vitreous Research Institute

Torrance, California, United States

Site Status

Bay Area Retina Associates

Walnut Creek, California, United States

Site Status

Retina Consultants of Southern Colorado

Colorado Springs, Colorado, United States

Site Status

RSC Research, LLC

Denver, Colorado, United States

Site Status

Colorado Retina Associates

Lakewood, Colorado, United States

Site Status

Retina Consultants, P.C

Manchester, Connecticut, United States

Site Status

Retina Group of New England

Waterford, Connecticut, United States

Site Status

Advanced Research LLC.

Deerfield Beach, Florida, United States

Site Status

Rand Eye Institute

Deerfield Beach, Florida, United States

Site Status

Retina Group of Florida

Fort Lauderdale, Florida, United States

Site Status

Florida Retina Consultants

Lakeland, Florida, United States

Site Status

South Florida Retina Institute

Miami, Florida, United States

Site Status

Florida Retina Institude

Orlando, Florida, United States

Site Status

Retina Specialty Institute

Pensacola, Florida, United States

Site Status

MedEye Associates

South Miami, Florida, United States

Site Status

Retina Vitreous Associates of Florida- Saint Petersburg

St. Petersburg, Florida, United States

Site Status

Retina Vitreous Associates of Florida

Tampa, Florida, United States

Site Status

Southeast Retina Center

Augusta, Georgia, United States

Site Status

University Retina and Macula Associates, PC

Oak Forest, Illinois, United States

Site Status

Illinois Retina Associates

Oak Park, Illinois, United States

Site Status

Springfield Clinic Opthalmology Department

Springfield, Illinois, United States

Site Status

Associate Vitreoretinal and Uveitis Consultants

Carmel, Indiana, United States

Site Status

Retina Partners Midwest, P.C.

Carmel, Indiana, United States

Site Status

Retina Partners Midwest

Indianapolis, Indiana, United States

Site Status

Wolfe Clinic PC dba Wolfe Eye Clinic

West Des Moines, Iowa, United States

Site Status

The Retina Group of Washington - Chevy Chase

Chevy Chase, Maryland, United States

Site Status

Cumberland Valley Retina Consultants

Hagerstown, Maryland, United States

Site Status

Mid Atlantic Retina Specialists

Hagerstown, Maryland, United States

Site Status

Retina Specialists - Towson Office

Towson, Maryland, United States

Site Status

Associated Retinal Consultants, P.C.

Royal Oak, Michigan, United States

Site Status

Retina Consultants of Minnesota

Minneapolis, Minnesota, United States

Site Status

Mississippi Retina Associates

Madison, Mississippi, United States

Site Status

The Retina Institute

St Louis, Missouri, United States

Site Status

Sierra Eye Associates

Reno, Nevada, United States

Site Status

Envision Ocular, LLC

Bloomfield, New Jersey, United States

Site Status

Vision Research Center Eye Associates of New Mexico

Albuquerque, New Mexico, United States

Site Status

Retina Vitreous Surgeons of CNY, PC

Liverpool, New York, United States

Site Status

Asheville Eye Associates (AEA) - Asheville

Asheville, North Carolina, United States

Site Status

Cincinnati Eye Institute

Cincinnati, Ohio, United States

Site Status

EyeHealth Northwest

Portland, Oregon, United States

Site Status

Erie Retina Research

Erie, Pennsylvania, United States

Site Status

Palmetto Retina Center, LLC

Aiken, South Carolina, United States

Site Status

Charleston Neuroscience Instititute, LLC

Beaufort, South Carolina, United States

Site Status

Palmetto Retina Center, LLC

Florence, South Carolina, United States

Site Status

Palmetto Retina Center, LLC

West Columbia, South Carolina, United States

Site Status

Black Hills Regional Eye Institute, LLP

Rapid City, South Dakota, United States

Site Status

Charles Retina Institute

Germantown, Tennessee, United States

Site Status

Southeastern Retina Associates PC

Johnson City, Tennessee, United States

Site Status

Tennessee Retina, PC

Nashville, Tennessee, United States

Site Status

Retina Research Institute of Texas

Abilene, Texas, United States

Site Status

Texas Retina Associates

Arlington, Texas, United States

Site Status

Austin Research Center for Retina

Austin, Texas, United States

Site Status

Austin Retina Associates

Austin, Texas, United States

Site Status

Retina Consultants of Texas

Beaumont, Texas, United States

Site Status

Retina Consultants of Texas

Bellaire, Texas, United States

Site Status

Star Vision Research

Burleson, Texas, United States

Site Status

Texas Retina Associates

Dallas, Texas, United States

Site Status

Texas Retina Center

Houston, Texas, United States

Site Status

Retina Consultants of Texas

Katy, Texas, United States

Site Status

Retina Consultants of Texas

San Antonio, Texas, United States

Site Status

Retina Center of Texas

Southlake, Texas, United States

Site Status

Retina Consultants of Texas

The Woodlands, Texas, United States

Site Status

Retina Associates of Utah

Salt Lake City, Utah, United States

Site Status

Rocky Mountain Retina Consultants

Salt Lake City, Utah, United States

Site Status

Retina Group of Washington

Fairfax, Virginia, United States

Site Status

Vistar Eye Center

Roanoke, Virginia, United States

Site Status

Eye Clinic of Wisconsin, SC

Wausau, Wisconsin, United States

Site Status

Organización Médica de Investigación (OMI)

Buenos Aires, , Argentina

Site Status

Centro Privado de Ojos

Buenos Aires, , Argentina

Site Status

Charles Research Center (Centro Oftalmologico Dr. Charles S.A)

Buenos Aires, , Argentina

Site Status

Buenos Aires Macula

Caba, , Argentina

Site Status

Instituto Oftalmologico de Buenos Aires SA - OFTALMOS

Caba, , Argentina

Site Status

Fundacion Zambrano - Cirugia Ocular

Caba, , Argentina

Site Status

Fundacion Jorge Zambrano para la investigacion, Diagnostico y Tratamiento de las enfermedades oculares

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

Oftar Mendoza Srl Centro Privado de Oftalmologia

Mendoza, , Argentina

Site Status

Centro Vision S.A.

Mendoza, , Argentina

Site Status

Laser Vision Group

Rosario, , Argentina

Site Status

Albury Eye Clinic

Albury, New South Wales, Australia

Site Status

Marsden Eye Specialists (MES) - Parramatta

Parramatta, New South Wales, Australia

Site Status

Emanuelli Research and Development Center, LLC

Arecibo, , Puerto Rico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Puerto Rico

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OTX-TKI-2023-AMD-303

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase II/III Study of Anti-VEGF in Neovascular AMD
NCT00021736 COMPLETED PHASE2/PHASE3